Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in RatsSolène Marie, Irene Hernández-Lozano, Marc Le Vée, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humansOliver Langer, Rudolf Karch, Ulrich Müller, et al.
Nuclear Medicine and Biology|June 3, 2017
[<sup>11</sup>C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in miceAlexander Traxl, Taraneh Beikbaghban, Thomas Wanek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a β-Amyloidosis Mouse Model with <sup>11</sup>C-Metoclopramide PETViktoria Zoufal, Severin Mairinger, Mirjam Brackhan, et al.
Bioorganic & Medicinal Chemistry|July 13, 2010
Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitorFlorian Bauer, Claudia Kuntner, Jens P Bankstahl, et al.
Journal of Medicinal Chemistry|August 29, 2009
Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrierBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
Molecular Imaging and Biology|June 27, 2018
Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[<sup>11</sup>C]Methylpurine in MiceViktoria Zoufal, Severin Mairinger, Markus Krohn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2007
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patientsAiman Abrahim, Gert Luurtsema, Martin Bauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 2, 2025
Imaging P-glycoprotein function at the blood-brain barrier in drug-resistant epilepsy using [<sup>11</sup>C]metoclopramideLouise Breuil, Inès Arino, Myriam El Biali, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 27, 2026
Imaging pulmonary P-glycoprotein activity with aerosolized [<sup>99m</sup>Tc]Tc-sestamibi in miceSeverin Mairinger, Jakob Pfeiffer-Vogl, Lena Zachhuber, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in RatsSolène Marie, Irene Hernández-Lozano, Marc Le Vée, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humansOliver Langer, Rudolf Karch, Ulrich Müller, et al.
Nuclear Medicine and Biology|June 3, 2017
[<sup>11</sup>C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in miceAlexander Traxl, Taraneh Beikbaghban, Thomas Wanek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a β-Amyloidosis Mouse Model with <sup>11</sup>C-Metoclopramide PETViktoria Zoufal, Severin Mairinger, Mirjam Brackhan, et al.
Bioorganic & Medicinal Chemistry|July 13, 2010
Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitorFlorian Bauer, Claudia Kuntner, Jens P Bankstahl, et al.
Journal of Medicinal Chemistry|August 29, 2009
Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrierBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
Molecular Imaging and Biology|June 27, 2018
Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[<sup>11</sup>C]Methylpurine in MiceViktoria Zoufal, Severin Mairinger, Markus Krohn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2007
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patientsAiman Abrahim, Gert Luurtsema, Martin Bauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 2, 2025
Imaging P-glycoprotein function at the blood-brain barrier in drug-resistant epilepsy using [<sup>11</sup>C]metoclopramideLouise Breuil, Inès Arino, Myriam El Biali, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 27, 2026
Imaging pulmonary P-glycoprotein activity with aerosolized [<sup>99m</sup>Tc]Tc-sestamibi in miceSeverin Mairinger, Jakob Pfeiffer-Vogl, Lena Zachhuber, et al.
Pageof 16